t-knife.com | T cell receptor engineered T cell therapies

Robots.txt Information

Robot	Path	Permission
GoogleBot	/	✔
BingBot	/	✔
BaiduSpider	/	✔
YandexBot	/	✔
User-agent: * Disallow: Crawl-delay:

Meta Tags

Title	T cell receptor engineered T cell therapies \| T-knife
Description	Discovering novel T cell T-knife Therapeutics is a biopharmaceutical company dedicated to developing novel therapeutics to fight
Keywords	N/A

Server Information

WebSite	t-knife.com
Host IP	81.169.145.84
Location	Germany

Related Websites

                        Site
                        Rank
                    

More to Explore

t-knife.com Valuation

US$8,467,694

Last updated: 2023-05-07 03:48:57

t-knife.com has Semrush global rank of 1,249,963. t-knife.com has an estimated worth of US$ 8,467,694, based on its estimated Ads revenue. t-knife.com receives approximately 977,042 unique visitors each day. Its web server is located in Germany, with IP address 81.169.145.84. According to SiteAdvisor, t-knife.com is safe to visit.

Traffic & Worth Estimates

Purchase/Sale Value	US$8,467,694
Daily Ads Revenue	US$7,817
Monthly Ads Revenue	US$234,490
Yearly Ads Revenue	US$2,813,880
Daily Unique Visitors	65,137
Note: All traffic and earnings values are estimates.

DNS Records

Host	Type	TTL	Data
t-knife.com.	A	298	IP: 81.169.145.84
t-knife.com.	AAAA	298	IPV6: 2a01:238:20a:202:1084::
t-knife.com.	NS	300	NS Record: shades05.rzone.de.
t-knife.com.	NS	300	NS Record: docks18.rzone.de.
t-knife.com.	MX	300	MX Record: 10 tknife-com0c.mail.protection.outlook.com.
t-knife.com.	TXT	300	TXT Record: v=spf1 include:spf.protection.outlook.com -all
t-knife.com.	TXT	300	TXT Record: docusign=034a36b3-9d09-458c-9717-2c92e62172c6
t-knife.com.	TXT	300	TXT Record: 2437B83213

HtmlToTextCheckTime:2023-05-07 03:48:57

About Management Board of Directors Scientific Advisory Board Technology TCR Therapies MyT™ Platform Scientific Publications Pipeline Pipeline Chart TK-8001 TCR-T TK-2504 TCR-T Clinical Trials News Press Releases Join Us Why T-knife Mission and Values Job Opportunities Contact Discovering novel T cell receptors We are focused on T cell receptor engineered T cell therapies, TCR-Ts, a promising modality that holds the potential to generate transformational responses in patients with solid tumors. Our unique approach to developing T cell therapies is based on our proprietary MyT platform, a next-generation T cell receptor and epitope discovery engine. We believe there are multiple benefits to leveraging our MyT platform to develop TCR-Ts. Discover novel, tumor-specific, human TCRs Generate TCRs of high affinity and specificity Target a broad array of cancer-related antigens Our Technology Advancing portfolio of TCR therapies for solid tumors Through the use of natural, fully human TCRs,

HTTP Headers

HTTP/1.1 301 Moved Permanently
Date: Wed, 27 Oct 2021 06:41:11 GMT
Server: Apache/2.4.51 (Unix)
X-Powered-By: PHP/7.3.31
Vary: Accept-Encoding,Cookie,User-Agent
X-Redirect-By: WordPress
Location: https://t-knife.com/
Content-Type: text/html; charset=UTF-8

HTTP/2 200 
date: Wed, 27 Oct 2021 06:41:12 GMT
server: Apache/2.4.51 (Unix)
x-powered-by: PHP/7.3.31
vary: Accept-Encoding,Cookie,User-Agent
link: ; rel="https://api.w.org/"
link: ; rel="alternate"; type="application/json"
link: ; rel=shortlink
content-type: text/html; charset=UTF-8

t-knife.com Whois Information

Domain Name: T-KNIFE.COM
Registry Domain ID: 1972295109_DOMAIN_COM-VRSN
Registrar WHOIS Server: whois.cronon.net
Registrar URL: http://www.cronon.net
Updated Date: 2020-10-28T07:09:06Z
Creation Date: 2015-10-27T10:31:53Z
Registry Expiry Date: 2021-10-27T10:31:53Z
Registrar: Cronon AG
Registrar IANA ID: 141
Registrar Abuse Contact Email: abuse-domains@cronon.net
Registrar Abuse Contact Phone: +4930398020
Domain Status: ok https://icann.org/epp#ok
Name Server: DOCKS18.RZONE.DE
Name Server: SHADES05.RZONE.DE
DNSSEC: unsigned
>>> Last update of whois database: 2021-09-15T04:21:42Z <<<

t-knife.com valuation and analysis